November 11, 2009 - Non-invasive treatment with the ExAblate Magnetic Resonance-guided Focused Ultrasound (MRgFUS) system by InSightec Ltd. reduces risk in treating symptomatic uterine fibroids, according to a study published in the November issue of Ultrasound in Obstetrics and Gynecology.

A prospective study of 192 patients at 14 different medical centers across the United States, Israel, the United Kingdom and Germany, showed that MRgFUS was associated with significantly fewer adverse events in comparison with hysterectomy patients. Similarly, recovery times were much faster for MRgFUS, with an average of only one day away from work as opposed to 6 weeks for hysterectomy.

In another report published in Ultrasound in Obstetrics and Gynecology, a separate study shows the positive correlation in the volume reduction of the fibroid to symptom improvement after two years.

Prof. Wladyslaw M. Gedroyc, St. Mary's Hospital, Imperial College Healthcare Trust, London, UK, wrote in an Opinion published in the November issue: "MRgFUS works quickly with very few side effects and that patients can return to normal function almost immediately after treatment. We also know that the larger the area of ablation that can be produced in the targeted fibroids, the better the symptomatic response and the less the need for other fibroid interventions, and that when the early symptomatic response is highly effective, long-term improvement of symptoms is almost invariably seen."

For more information: www.insightec.com


Related Content

News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 23, 2024 — Researchers at the National Institutes of Health (NIH) found that an artificial intelligence (AI) model ...

Time July 23, 2024
arrow
News | Radiology Business

July 19, 2024 — GE HealthCare announced it has entered into an agreement to acquire Intelligent Ultrasound Group PLC’s ...

Time July 19, 2024
arrow
News | Artificial Intelligence

July 17, 2024 — Hyperfine, a groundbreaking medical device company that has redefined brain imaging with the world’s ...

Time July 17, 2024
arrow
News | Prostate Cancer

July 11, 2024 — GE HealthCare’s MIM Software, a global provider of medical imaging analysis and artificial intelligence ...

Time July 11, 2024
arrow
Feature | Women's Health | By Jordan Bazinsky

Investing in women’s health should not merely be a metric on the equity dashboard — it should drive policy and tactical ...

Time July 08, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Clinical Trials

June 27, 2024 — Prenuvo, which makes whole-body MRI screening for early cancer detection and other diseases, has ...

Time June 27, 2024
arrow
News | Pediatric Imaging

June 25, 2024 — Rady Children’s Hospital-San Diego, one of the nation’s top pediatric health care systems, today ...

Time June 25, 2024
arrow
Subscribe Now